Pure Global

Sirolimus Eluting Coronary Side Branch Stent System - India CDSCO Medical Device Registration

Sirolimus Eluting Coronary Side Branch Stent System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2018/000028_d13c8ee1730ba1db3120866c8d84eb15_b474516ca0ada73d8bbd265cacccf9db. This device is marketed under the brand name First Brand. The license holder is Meril Life Sciences Pvt. Ltd., and it is classified as Device Class Class D. The approving authority is Central Drug Standards Control Organization, Ahmedabad.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class D
Sirolimus Eluting Coronary Side Branch Stent System
UID: MFG/MD/2018/000028_d13c8ee1730ba1db3120866c8d84eb15_b474516ca0ada73d8bbd265cacccf9db

Brand Name

First Brand

Device Class

Class D

Approving Authority

Central Drug Standards Control Organization, Ahmedabad

Product Information

It is intended for improving the coronary luminal diameter of the side branch of de novo bifurcation lesions in-stent restenotic lesions in native coronary arteries with reference diameters ranging from 2.5 mm to 3.5 mm in the side branch and 2.5 mm to 4.0 mm in the main vessel. The device is intended for use in conjunction with balloon expandable coronary stents (First Brand) in the main branch

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing